Tristan Thompson’s unfaithfulness extends beyond his personal life into his professional career, particularly in the NBA. Today, the league dropped a bombshell, announcing the suspension of the Cleveland Cavaliers’ player without pay for a substantial 25 games. The reason? Violation of the NBA/NBPA Anti-Drug Program due to testing positive for ibutamoren and SARM LGD-4033.
Commencing with tomorrow’s game against the Milwaukee Bucks, Thompson’s suspension sheds light on a darker side of his professional journey. If you’re curious about the specifics of the substances detected in his system, the co-administration of LGD-4033 and MK-677 is unveiled, showcasing significant impacts on body mass, lean mass, fat mass, and various health markers.
The revealed insights from cross-sectional data suggest potential alterations in intramuscular androgenic hormone and receptor concentrations, alongside the promotion of muscular strength.
These findings, when compared to previously published data from trained males, raise questions about the extent of these compounds’ influence.
In the aftermath of this revelation, Thompson will face the consequences with a suspension without pay, leaving fans and critics alike speculating about the future of his NBA career.
Featured image from: Photo by Fernando Medina/NBAE via Getty Images